Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Group 1 - The article introduces Ezequiel Szyrko as a new contributing analyst for Seeking Alpha, highlighting his investment approaches which include GARP, Value, and Growth strategies [1] - The analyst emphasizes the importance of monitoring insider buying and stock buybacks, as well as utilizing technical analysis tools such as Elliott Wave, EMA crossovers, and chart patterns [1] Group 2 - The article discloses that the analyst has a beneficial long position in the shares of FLGT, indicating a personal investment interest in the company [2] - It is noted that the opinions expressed in the article are solely those of the analyst and not influenced by any business relationships with companies mentioned [2]